American Society of Clinical Oncology

SHERPA: White

People

  1. Motzer
    Motzer
  2. Scher
    Scher
  3. O'Reilly
    O'Reilly
  4. Saltz
    Saltz
  5. Bajorin
    Bajorin
  6. Hudis
    Hudis
  7. Morris
    Morris
  8. Kris
    Kris
  9. Rosenberg
    Rosenberg
  10. Abou-Alfa
    Abou-Alfa

Groups

  1. Department of Medicine (6126)
  2. Solid Tumor Oncology Division (5298)
  3. Survivorship Research (1893)
  4. Genitourinary Oncology Service (1713)
  5. Surgery (1568)
  6. Epidemiology and Biostatistics (1403)
  7. GSK Faculty (1295)
  8. Gastrointestinal Oncology Service (1290)
  9. Population Sciences Research Program (1263)
  10. Hematologic Malignancies, Division of (1233)
Search Within
  1. "Journal of Clinical Oncology"
Formats
  1. Meeting Abstract (6344)
  2. Journal Article (2165)
  3. Editorial (68)
  4. Guidelines (54)
  5. Correspondence (45)
  6. Review (33)
  7. Miscellaneous (4)
  8. Conference Paper (2)
Groups
  1. Department of Medicine (6126)
  2. Solid Tumor Oncology Division (5298)
  3. Survivorship Research (1893)
  4. Genitourinary Oncology Service (1713)
  5. Surgery (1568)
  6. Epidemiology and Biostatistics (1403)

More Groups

People
  1. Robert Motzer (448)
  2. Howard Scher (328)
  3. Eileen O'Reilly (296)
  4. Leonard Saltz (271)
  5. Dean Bajorin (270)
  6. Clifford Hudis (246)

More People

Years
  1. 2025 (266)
  2. 2024 (521)
  3. 2023 (553)
  4. 2022 (520)
  5. 2021 (471)
  6. 2020 (500)

More Years

Publications
  1. Journal of Clinical Oncology (8715)

Results (8715)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Cost-effectiveness of total neoadjuvant therapy with selective nonoperative management for locally advanced rectal cancer: Analysis of data from the organ preservation for rectal adenocarcinoma trial
    Journal Article

    Widmar, M.; McCain, M.; Meza, A. M.; Ternent, C.; Briggs, A.; Garcia-Aguilar, J.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Reply to: Significance of up-front stereotactic radiosurgery for non-small cell lung cancer patients with brain metastases in the era of new generation tyrosine kinase inhibitors
    Correspondence

    Rusthoven, C. G.; Miao, E.; Boe, L. A.; Pike, L. R. G.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Guidance for JCO authors on subgroup representation and reporting
    Editorial

    Wheeler, S. B.; Iasonos, A.; Cheng, I.; Craddock, C.; Miller, K. D.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Primary analysis of EPIK-O/ENGOT-ov61: Alpelisib plus olaparib versus chemotherapy in platinum-resistant or platinum-refractory high-grade serous ovarian cancer without BRCA mutation
    Journal Article

    Konstantinopoulos, P. A.; Kim, J. W.; Freyer, G.; Lee, J. Y.; Gaba, L.; Grisham, R. N.; Colombo, N.; Wu, X.; Sehouli, J.; Cruz, F.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Germline pathogenic/likely pathogenic mutations and subsequent neoplasms among childhood cancer survivors: A report from the Children's Oncology Group ALTE03N1 study
    Journal Article

    Zhou, L.; Singh, P.; Crossman, D.; Richman, J.; Trainor, P.; Cheng, C.; Wang, X.; Sharafeldin, N.; Hageman, L.; Sheikh, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Mediastinal nodal evaluation may be safely omitted in select patients with ground glass-dominant lung adenocarcinoma
    Editorial

    Chidi, A. P.; Jones, D. R.
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Long-term follow-up of E3311, an ECOG-ACRIN cancer research group phase II trial of transoral surgery and risk-based adjuvant treatment in human papillomavirus-initiated oropharynx cancer
    Journal Article

    Burtness, B.; Flamand, Y.; Quon, H.; Weinstein, G. S.; Mehra, R.; Garcia, J. J.; Kim, S.; O'Malley, B. W. Jr; Ozer, E.; Ikpeazu, C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • International Myeloma Society/International Myeloma Working Group consensus recommendations on the definition of high-risk multiple myeloma
    Guidelines

    Avet-Loiseau, H.; Davies, F. E.; Samur, M. K.; Corre, J.; D'Agostino, M.; Kaiser, M. F.; Raab, M. S.; Weinhold, N.; Gutierrez, N. C.; Paiva, B.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Phase 2 dose expansion of START-001: A phase 1/2 study of invikafusp alfa (STAR0602), a first-in-class, selective T cell receptor (TCR)-targeting, bifunctional antibody-fusion molecule, as monotherapy in patients with antigen-rich tumors resistant to anti-PD(L)-1
    Meeting Abstract

    Friedman, C. F.; Sullivan, R. J.; Tschernia, N.; Sonpavde, G. P.; Herrera, M.; He, K.; Bilusic, M.; Garralda, E.; Hernando-Calvo, A. H.; Silk, A. W.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • SUPRAME: A phase 3 trial comparing IMA203, an engineered T-cell receptor expressing T cell therapy (TCR-T) vs investigator's choice in patients with previously treated advanced cutaneous melanoma
    Meeting Abstract

    Luke, J. J.; Warner, A. B.; Chmielowski, B.; Diab, A.; Gebhardt, C.; Hernandez-Aya, L. F.; Hu-Lieskovan, S.; Karapetyan, L.; Lawrence, D. P.; McKean, M.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save